BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11723233)

  • 21. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development.
    Kamiya A; Inoue Y; Gonzalez FJ
    Hepatology; 2003 Jun; 37(6):1375-84. PubMed ID: 12774017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines.
    Scheer N; Kapelyukh Y; McEwan J; Beuger V; Stanley LA; Rode A; Wolf CR
    Mol Pharmacol; 2012 Jan; 81(1):63-72. PubMed ID: 21989258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1.
    Yu X; Mertz JE
    J Virol; 2003 Feb; 77(4):2489-99. PubMed ID: 12551987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
    Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
    Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals.
    Jiang F; Yeo CW; Lee SS; Oh MK; Ghim JL; Shon JH; Kim HS; Kim EY; Kim DH; Shin JG
    Pharmacogenet Genomics; 2013 Mar; 23(3):175-9. PubMed ID: 23292115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transcription factor regulatory circuit in differentiated pancreatic cells.
    Boj SF; Parrizas M; Maestro MA; Ferrer J
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14481-6. PubMed ID: 11717395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2D6 polymorphism is not crucial for the disposition of selegiline.
    Scheinin H; Anttila M; Dahl ML; Karnani H; Nyman L; Taavitsainen P; Pelkonen O; Bertilsson L
    Clin Pharmacol Ther; 1998 Oct; 64(4):402-11. PubMed ID: 9797797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a conditionally null allele of hnf4alpha.
    Parviz F; Li J; Kaestner KH; Duncan SA
    Genesis; 2002 Feb; 32(2):130-3. PubMed ID: 11857799
    [No Abstract]   [Full Text] [Related]  

  • 30. Substrate specificity of CYP2D6 genetic variants.
    van der Lee M; Guchelaar HJ; Swen JJ
    Pharmacogenomics; 2021 Nov; 22(16):1081-1089. PubMed ID: 34569808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types.
    Nakhei H; Lingott A; Lemm I; Ryffel GU
    Nucleic Acids Res; 1998 Jan; 26(2):497-504. PubMed ID: 9421506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree.
    Lausen J; Thomas H; Lemm I; Bulman M; Borgschulze M; Lingott A; Hattersley AT; Ryffel GU
    Nucleic Acids Res; 2000 Jan; 28(2):430-7. PubMed ID: 10606640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205.
    Maeda Y; Rachez C; Hawel L; Byus CV; Freedman LP; Sladek FM
    Mol Endocrinol; 2002 Jul; 16(7):1502-10. PubMed ID: 12089346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine.
    Granvil CP; Krausz KW; Gelboin HV; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1025-32. PubMed ID: 12023534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing.
    Torres-Padilla ME; Fougère-Deschatrette C; Weiss MC
    Mech Dev; 2001 Dec; 109(2):183-93. PubMed ID: 11731232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6.
    Hayhurst GP; Harlow J; Chowdry J; Gross E; Hilton E; Lennard MS; Tucker GT; Ellis SW
    Biochem J; 2001 Apr; 355(Pt 2):373-9. PubMed ID: 11284724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.
    Felmlee MA; Lon HK; Gonzalez FJ; Yu AM
    Drug Metab Dispos; 2008 Feb; 36(2):435-41. PubMed ID: 18048490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of the HNF4alpha isoform (HNF4alpha8) expressed in pancreatic beta-cells.
    Ihara A; Yamagata K; Nammo T; Miura A; Yuan M; Tanaka T; Sladek FM; Matsuzawa Y; Miyagawa J; Shimomura I
    Biochem Biophys Res Commun; 2005 Apr; 329(3):984-90. PubMed ID: 15752752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted insertion of an IRES Cre into the Hnf4alpha locus: Cre-mediated recombination in the liver, kidney, and gut epithelium.
    Vincent SD; Robertson EJ
    Genesis; 2004 Jul; 39(3):206-11. PubMed ID: 15282747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.